Detalhe da pesquisa
1.
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.
J Eur Acad Dermatol Venereol
; 36(10): 1774-1783, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460287
2.
Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2).
Br J Dermatol
; 185(2): 323-334, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33544883
3.
Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks.
Br J Dermatol
; 182(3): 605-617, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31218661
4.
Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.
J Eur Acad Dermatol Venereol
; 34(1): 119-126, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465585
5.
First-line treatment in lymphomatoid papulosis: a retrospective multicentre study.
Clin Exp Dermatol
; 43(2): 137-143, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28994134
6.
Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm® - and placebo-controlled trial (BRIDGE).
Br J Dermatol
; 176(3): 615-623, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515097
7.
Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials.
J Eur Acad Dermatol Venereol
; 35(11): e709-e711, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34058035
8.
Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy.
J Eur Acad Dermatol Venereol
; 28(8): 1097-1102, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25243267
9.
[Skin signs in child abuse]. / Signos cutáneos del maltrato infantil.
Actas Dermosifiliogr
; 103(2): 94-9, 2012 Mar.
Artigo
em Espanhol
| MEDLINE | ID: mdl-21737054
10.
Acquired hypopigmented suprapubic macules.
Clin Exp Dermatol
; 39(5): 655-7, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24758414